Alcohol use disorder: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• GLP-1 3
• NMDA 1

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

No running funded project names this disease yet.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2

  NCT06006143· Yale University· Updated 6 Nov 2026

  “recruitment challenges”Registry text, quoted unchanged. Source

• Suspended

  The Effects of Sex Hormones and Alcohol on Sleep

  NCT06143059· Ohio State University· Updated 28 Sept 2026

  “PI transferring work elsewhere”Registry text, quoted unchanged. Source

• Terminated

  Cognitive Enhancement Through Computerized Training

  NCT04244032· University of Florida· Updated 16 Sept 2026

  “enrollment barriers”Registry text, quoted unchanged. Source

• Terminated

  Decision Making in Chronic Pain and Alcohol Use Disorder

  NCT05901610· Kirstin M Gatchalian· Updated 14 Sept 2026

  “personnel availability and challenges with eligibility”Registry text, quoted unchanged. Source

• Terminated

  Neuromodulation and Cognitive Training for Substance Use Disorders

  NCT04426214· University of Minnesota· Updated 10 Aug 2026

  “closed to accrual due to change in practice; no longer seeing eligible participants.”Registry text, quoted unchanged. Source

• Terminated

  Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

  NCT06624137· Yale University· Updated 9 Jul 2026

  “Funding ended.”Registry text, quoted unchanged. Source

• Withdrawn

  Contingency Management Using Deposit Contract to Reduce Drinking

  NCT05837611· The University of Texas Health Science Center at San Antonio· Updated 23 Jun 2026

  “Due to a study transfer between institutions, substantial time and funding was lost. Additionally, other federal funding cancellations resulted in a loss of staff.”Registry text, quoted unchanged. Source

• Terminated

  Cannabidiol for Reducing Drinking in Alcohol Use Disorder

  NCT05159830· Hôpital le Vinatier· Updated 12 Jun 2026

  “Péremption des unités de traitement prévue début juin 2026. Compte tenu des délais de traitement, aucune administration ne sera plus possible après le 1 février 2026. Ces facteurs ne permettent plus de garantir la poursuite des inclusions.”Registry text, quoted unchanged. Source

• Suspended

  Improving Alcohol Use Disorder Treatment for Gender Minority Populations

  NCT05070793· New York State Psychiatric Institute· Updated 22 May 2026

  “Institutional Research Pause”Registry text, quoted unchanged. Source

• Terminated

  iTBS for Alcohol Use Disorder

  NCT06696365· Nicholas Balderston, PhD· Updated 30 Apr 2026

  “Change in staffing at site. Two participants were enrolled. No usable data was collected from these participants.”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Implementing an Evidence-based Alcohol Use and Sexual Risk Intervention in Young Adult Homeless Service Settings

  NCT07933406· RAND· Source

• Sex Differences in the Response to Abstinence From Alcohol.

  NCT03827460· Indiana University· Source

• Study to Evaluate ALN-CIDEB in Adults With Fibrotic Alcohol-Associated Liver Disease (ALD)

  NCT07933328· Regeneron Pharmaceuticals· Source

• Piloting a Deaf Accessible Pre-Treatment for AUD

  NCT07269119· University of Massachusetts, Worcester· Source

• Spironolactone in Alcohol Use Disorder (SAUD)

  NCT05807139· National Institute on Drug Abuse (NIDA)· Source

• Trial Phase: Syndemic Adapted Medly Uganda

  NCT07525271· Yale University· Source

• Evaluating the Effectiveness of Implementation Intentions to Strengthen Approach-avoidance Training

  NCT06211959· Clinique de la Mitterie· Source

• NIAAA Natural History Protocol

  NCT02231840· National Institute on Alcohol Abuse and Alcoholism (NIAAA)· Source

• Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes

  NCT07772960· Yale University· Source

• eTSF for Latinx Young Adults With Alcohol Use Disorder

  NCT06722690· University of Texas at Austin· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

See which targets of this disease your abstract mentions, and go to the people working on them.